The Portuguese infection control market is poised to reach US$104.069 million by 2027, at a CAGR of 5.35%. The market was valued at US$72.238 million in 2020.
Compared to 2017’s nominal expenditure of 3.6%, the health expenditure of Portugal increased to 5.1% in 2018. Both public and private current expenditures increased by 3.6% in 2017. The relative importance of public current expenditure in financing the Portuguese health system remained at 66.3%. For 2018, an increase in public spending (5.3%) higher than that of private expenditure (4.6%), was foreseen [Source: Instituto Nacional de Estatística – Portugal (Statistics Portugal)].
The expenditure of public hospitals and public providers of ambulatory health care grew 4.1% in 2017, due to the increase in intermediate consumption, which is inclusive of but not limited to pharmaceuticals and clinical consumables and personnel costs, which includes an increase in the number of workers, among other reasons. On the other hand, the expenditure of private providers, hospitals, and providers of ambulatory health care grew at a faster pace, with increases of 5.5% and 4.4%, respectively. Owing to the burgeoning healthcare sector and the increase in healthcare-related expenditure borne by both the government and private entities, the market for infection control in Portugal is expected to see robust growth within the anticipated time.
Furthermore, the tourism sector, before the advent of the unforeseen pandemic called COVID-19, has substantially contributed to the factors leading to the growth of the infection control market in Portugal.
It is important to note that the tourist accommodation sector registered 1.4 million guests and 3.3 million overnight stays in January 2020. Overnight stays of residents grew by 12.1% (+4.5% in December 2019) and those of non-residents increased by 5.6%.
To this extent, it is important to note that the tourist accommodation sector registered 1.4 million guests and 3.3 million overnight stays in January 2020, corresponding to year-on-year rates of change of +12.2% and +7.6%, respectively. Overnight stays of residents grew by 12.1%, which is a 4.5% increase from December 2019; those of non-residents increased by 5.6% (+9.3% in the preceding month). Total revenue increased by 7.2% (+9.1%) to EUR 175.9 million in December 2019. Revenue from accommodation stood at EUR 124.8 million, growing by 8.5% (+9.4% in the preceding month of December 2019). The average revenue per available room (RevPAR) increased by 4.5% to EUR 25.1 (+4.7% in December 2019). The average daily rate (ADR) reached EUR 68.6, increasing by 2.9%, i.e., +0.9% in the preceding month.
In January 2020, the whole set of means of accommodation (tourist accommodation establishments, camping sites, holiday camps, and youth hostels) registered 1.5 million guests and 3.5 million overnight stays [Source: Instituto Nacional de Estatística – Portugal (Statistics Portugal)]. Thus, the food and beverage products already requisitioned before the pandemic and the running of daily operations, which includes the dispensing of food and beverage preparation, among others, will lead to steady growth in the Infection Control Market of Portugal.
Key Developments
Impact of the COVID-19 pandemic
The market for infection control in Ireland has been significantly impacted by the COVID-19 epidemic. Worldwide healthcare systems have been devastated by the pandemic, with hospitals becoming overcrowded as patient numbers rise. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely in the post-COVID situation.
Segmentation